# A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

> clinical trial · VERIFIED · 2026-08-14

Status: RECRUITING · Sponsor: Kite, A Gilead Company · Condition: Chronic Inflammatory Demyelinating Polyneuropathy

- Company: Kite, A Gilead Company
- Sector: neurotech
- Primary source: https://clinicaltrials.gov/study/NCT07304154

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.